• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Going for the Growth

These stocks have been making big moves -- up and down -- despite the market whipsaws caused by Europe.
By KATE STALTER Nov 04, 2011 | 02:45 PM EDT
Stocks quotes in this article: RL, GMCR, MA, ISRG, DECK, SBUX, NFLX, PRGO, AH

This earnings season, European developments have overshadowed company news. Though broad market whipsaws have become the norm, some individual stocks have been making big moves -- sometimes independent of the market -- following their earnings reports.

For example, MasterCard (MA), Intuitive Surgical (ISRG), Deckers Outdoor (DECK) and Starbucks (SBUX) are among the growth stocks that bolted higher on better-than-expected quarterly reports and guidance.

On the flip side, Netflix's (NFLX) post-earnings gap-down was widely publicized. Less well known is Perrigo's (PRGO) 8.5% gap lower Oct. 27, after the generic drugmaker's third-quarter report. Netflix's shortcomings are pretty much common knowledge: After a series of missteps, the company reported discouraging numbers about customer defections. What happened at Perrigo? It beat views and issued good guidance, but analysts said competition in its industry is heating up -- hence the gap-down.

I've been considering these moves ahead of reports from a few growth names that are expected next week. Growth names -- even large-caps like MasterCard or Starbucks -- can often show bigger price moves than so-called blue chips, or dividend-paying DJIA components.

With that in mind, I'm eyeing Wednesday's third-quarter report from Accretive Health (AH), which I have been tracking as a watch-list candidate. The company provides a range of management services to hospitals and other health care providers. Ahead of its report, the stock has some positive characteristics. First, the company boasts solid earnings growth in the past three quarters. The mid-cap's evenue has been 21% or higher during that time. And it has a solid return on equity of 28%.

The stock is also youthful, having gone public in May 2010. Newly public companies frequently sport some of the market's best growth. Technically, there's a reason for optimism: Its most recent price consolidation undercut the prior intermediate lows. Such price action can mean that investors lacking conviction have been flushed out, and new money enters the stock as value investors jump in. Upside volume has been slightly above average recently.

After a very orderly run-up along the10-week average last year and early this year, the character of trading has changed since May, becoming more erratic, as trading in the indices did the same. While this stock is still about 18% below its previous high, it's too far from a technical buy point for me to consider. However, good earnings and guidance could result in an upside move. I'll be watching the earnings news carefully.

I've also been tracking Ralph Lauren (RL), which reports its second quarter on Wednesday. Analysts expect year-over-year gains for the fashion icon's top and bottom lines.

The stock's recent price action has been sloppy, with wide price swings in tandem with the broader market. It pulled back from last week's all-time high of $164.55, but found support at its 20-day moving average. If that support holds, the stock could offer a buy point between that recent level and the prior high.

Many of its clothing-industry peers have been solid fundamental and technical performers lately. Strength from industry peers following earnings is an encouraging sign; if this company follows those precedents, the report and guidance could bode well.

Finally, one of the most closely watched growth names, Green Mountain Coffee Roasters (GMCR) reports after Wednesday's close. The stock is trading almost 40% below its September all-time high of $115.98. That's a fairly steep correction, and I'm not inclined to enter this stock any time soon.

Hedge fund manager David Einhorn recently made negative comments about the company's business prospects, but plenty of analysts disagreed. The proof will be in the numbers Wednesday, with traders also listening for guidance.

The current price decline is larger than ideal, even for a growth stock, which can correct at a higher rate than the general market in a downturn. However, there could be a silver lining: As noted in the discussion about Accretive Health, a pullback that undercuts prior lows can attract bargain shoppers, who send the stock higher again.

But the story behind Green Mountain has taken on added significance lately, so this next earning report has the potential to provide a caffeine-like jolt to investors.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Stalter had no positions in the stocks mentioned.

TAGS: Investing | U.S. Equity | Healthcare | Consumer Discretionary

More from Healthcare

Johnson & Johnson Appears to Be Running Out of Steam

Bruce Kamich
Jun 22, 2022 8:25 AM EDT

The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.

Anthem's Long-Term Uptrend Is Losing Its Vigor

Bruce Kamich
Jun 22, 2022 7:40 AM EDT

The technical signals of the health benefits provider are weakening.

Here Are 2 Prudent Healthcare Trades

Bret Jensen
Jun 17, 2022 11:30 AM EDT

The country might be heading into recession, but folks still need to get their medicine, good times or bad.

Here's the Level to Zero In on for UnitedHealth Group

Bruce Kamich
Jun 13, 2022 7:29 AM EDT

Shares of the diversified healthcare company have held up fairly well despite the decline in the broader market but soon could be put to the test.

3 Dividend-Paying Healthcare Stocks That Age Well

Bob Ciura
Jun 5, 2022 12:30 PM EDT

Within the next 15 years, people 65 or older are expected outnumber those under 18, for the first time in U.S. history.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • 12:08 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    As a Portfolio Name Agrees to a Merger, Here's Our...
  • 10:44 AM EDT PAUL PRICE

    My Very Best Pick for the Next 12 Months

    American Woodmark . It rarely gets better than th...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login